
Cardurion
Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. The company's therapeutics offer advanced novel mechanisms to develop new treatments for heart diseases, causing mor...
Valuation
$760M
Latest known
Share Price
N/A
Total Raised
$621.8M
Last Round
N/A